Skip to main content
Back to News
Valinor secured $13 million in seed funding to scale its AI platform for patient selection in clinic...
Funding
1 min read
US

Valinor secured $13 million in seed funding to scale its AI platform for patient selection in clinic...

The AMW Read

This is a standard seed-stage funding announcement for a new player in the Vertical AI healthcare sub-segment; it does not meet the $500M threshold for cross.Β§D.
NoveltySignificance
Healthcare & Bio Β· Player Map
Valinor Discovery
Valinor Discovery

AI in Healthcare

View Company Profile

Valinor secured $13 million in seed funding to scale its AI platform for patient selection in clinical trials. This investment accelerates the use of multimodal machine learning to predict patient responses, reducing development costs and improving trial success rates. The advancement promises faster delivery of life-saving treatments. #AIinHealthcare #ClinicalTrials #Biotech #MachineLearning #DrugDevelopment

Explore Valinor DiscoveryRead Original

How This Connects

Based on Healthcare & Bio Β· Player Map

  1. 2d agoMoleculeOS launches as AI operating system for biology R&D, signaling platform shift in drug discoveryMoleculeOS
  2. 1w agoAnthropic releases Claude Science Beta, a multi-agent AI workbench designed to run end-to-end resear...Anthropic
  3. 1w agoBaiyao Tech (η™Ύζ›œη§‘ζŠ€) releases AURA CellOS, first AI virtual cell based on LLM-JEPA architecture.η™Ύζ›œη§‘ζŠ€
  4. 1w agoAnthropic launches Claude Science AI workbench for life sciences researchAnthropic
  5. 7mo agoValinor secured $13 million in seed funding to scale its AI platform for patient selection in clinic... Β· THIS ARTICLE

More news from Valinor Discovery

Stay updated with the latest news and announcements from Valinor Discovery.

View all Valinor Discovery news

Discover AI Startups

Explore 2,000+ AI companies with VC-grade analysis, funding data, and investment insights.

Explore Dashboard